TD Cowen, Royal Bank of Canada, and Oppenheimer Holdings reaffirmed ratings and raised price targets for Incyte stock.

The entities involved

• TD Cowen →

  American investment bank

  • Analyst downgraded Ag Growth International Inc. due to debt management risks.Mon 12:33
  • TD Cowen raised its price target and gave a buy rating for Travere Therapeutics, Inc., while various institutional investors bought into the company.Mon 10:36
• Incyte →

  American pharmaceutical company

  • Incyte, a biotech company based in Wilmington, outperformed the biotech ETF.Thu 13:11
• Royal Bank of Canada →

  financial institution in Canada

  • Royal Bank of Canada raised its holdings in the Dimensional US Sustainability Core 1 ETF on June 19, 2026.Mon 16:02
  • PrairieSky Royalty Ltd. operates in the Western Canadian Sedimentary Basin and is currently receiving research ratings from Royal Bank of Canada (RBC).Mon 09:02

Related events

• TD Cowen upgraded shares of Incyte to strong-buy rating and adjusted price targets on August 25, 2026.Aug 25
• Multiple financial institutions, including Citigroup, Royal Bank of Canada, and Deutsche Bank, issued rating changes and set target prices.Sep 12
• Rating firms Raymond James Financial and TD Cowen provided reaffirmed buy ratings and price targets for a company listed on Nasdaq.Thu 23:04
• Wellington Management reduced its stock holdings in Incyte, alongside sales by EVP Patrick Mayes and insider Pablo Cagnoni.Aug 30
• TD Cowen reaffirmed a 'hold' rating on the shares of Commerce Bancshares, Inc. on July 25, 2026.Jul 25